Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Settlement Looks To Ground Airborne Claims

This article was originally published in The Tan Sheet

Executive Summary

Under a settlement with the Federal Trade Commission announced Aug. 14, the maker of Airborne dietary supplement products must cease unsubstantiated health-related claims and contribute up to $6.5 million to an existing consumer redress fund

You may also be interested in...



NAD Refers Star Herbs Blood Pressure Claims To FTC

The industry self-regulation group refers My Low Press supplement claims after Star Herbs fails to offer evidence to support its advertising. Referring uncooperative firms to FTC “was one of the things that we found attractive when we created our program with the NAD,” said CRN President and CEO Steve Mister.

NAD Refers Star Herbs Blood Pressure Claims To FTC

The industry self-regulation group refers My Low Press supplement claims after Star Herbs fails to offer evidence to support its advertising. Referring uncooperative firms to FTC “was one of the things that we found attractive when we created our program with the NAD,” said CRN President and CEO Steve Mister.

False Advertising Insurance Among Options For Changing Supplement Industry

Insurance brokers specializing in dietary supplement firms seek new coverage avenues as many manufacturers have cleaned up their act and lowered their product liability risk.

Related Content

Topics

UsernamePublicRestriction

Register

PS102001

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel